The supplements giant also announced that Dr Mark Gelbert has been appointed to the position of Chief Scientific Officer, leading the research, development and innovation efforts.
Prior to joining Nature’s Bounty, Dr Gelbert was Senior Vice President of Global R&D and Switch for Pfizer Consumer Healthcare and a member of its Global Leadership Team.
“Mark’s expertise and ability to turn scientific advances into market-leading products will be a tremendous asset to The Nature’s Bounty Co. going forward,” said CEO Paul Sturman.
“I am thrilled to be joining The Nature’s Bounty Co. and energized by the incredible opportunities for innovation and creativity that are in front of us,” said Dr. Gelbert. “Consumers are increasingly involved in their own healthcare decisions and solutions. Using research and science to drive new innovation allows us to meet those needs in creative, safe and effective ways.”